Fundraising Fox
StarTric
6 employees on LinkedIn · 3 known investors
Find your way into StarTric
Sign up to see every warm intro you have to StarTric
- Paths you didn't know you had: your email and LinkedIn already hold routes to the StarTric team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation. The device targets cardiology centers and TR patients who cannot undergo open surgery; it is currently under development and not yet available for clinical use.
Founders & leadership
MD
Michele De BonisFounder
OA
Ottavio AlfieriFounder
Investors · 3
Growth Capitallisted by Growth CapitalMilan · $200K
How we know: Growth Capital's portfolio page · Not right? Tell us
Growth Enginelisted by Growth EngineMilan
How we know: Growth Engine's portfolio page · funding news · Not right? Tell us
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does StarTric do?
- StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation. The device targets cardiology centers and TR patients who cannot undergo open surgery; it is currently under development and not yet available for clinical use.
- Who founded StarTric?
- StarTric was founded by Michele De Bonis, Ottavio Alfieri.
- Who are StarTric's investors?
- StarTric's investors include Growth Capital, Growth Engine, NLC.